Genotoxicity of furan in Big Blue rats

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 742, Issue 1-2, 2012, Pages 72-78

  McDaniel, L Patrice ^a   Ding, Wei ^a   Dobrovolsky, Vasily N ^a   Shaddock, Joseph G ^a   Mittelstaedt, Roberta A ^a   Doerge, Daniel R ^a   Heflich, Robert H ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Cancer mode of action; Comet assay; Hprt mutation; Micronucleus assay; Pig a mutation

Indexed keywords

CELL PROTEIN; FURAN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; PIG A PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGEN TESTING; CONTROLLED STUDY; ERYTHROCYTE; GENE MUTATION; GENOTOXICITY; LYMPHOCYTE; MALE; MICRONUCLEUS TEST; NONHUMAN; NORMOCHROMATIC ERYTHROCYTE; PRIORITY JOURNAL; RAT; RETICULOCYTE; SPLEEN CELL; TRANSGENIC RAT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DRUG ADMINISTRATION SCHEDULE; FURANS; MALE; MUTAGENICITY TESTS; MUTAGENS; RATS;

RATTUS; SUIDAE;

EID: 84856111191     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2011.12.011     Document Type: Article

References (53)

1. IARC (International Agency for Research on Cancer) Dry cleaning, furan. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Some Chlorinated Solvents and other Industrial Chemicals, vol. 63 1995, 393-407. IARC, Lyon.
2. U.S. FDA (U.S. Food and Drug Administration), Exploratory Data on Furan in Food, Data Through April 28, 2004, (accessed 8-21-2011). http://www.fda.gov/ohrms/dockets/ac/04/briefing/4045b2_09_furan%20data.pdf.
3. U.S. FDA (U.S. Food and Drug Administration), Exploratory Data on Furan in Food: Individual Food Products, Data Through September 17, 2008, (site accessed 8-3-2011). http://www.fda.gov/Food/FoodSafety/FoodContaminantsAdulteration/ChemicalContaminants/Furan/ucm078439.htm.
4. NTP (National Toxicology Program), Toxicology and Carcinogenesis Studies of Furan (CAS No. 110-00-9) in F344/N Rats and B6C3F1 Mice (Gavage Studies), in: NTP Technical Report Series No. 402, NTP, Research Triangle Park, NC, 1993, pp. 1-287.
5. Kedderis G.L. Extrapolation of in vitro enzyme induction data to humans in vivo. Chem.-Biol. Interact. 1997, 107:109-121.
6. Kedderis G.L., Carfagna M.A., Held S.D., Batra R., Murphy J.E., Gargas M.L. Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro. Toxicol. Appl. Pharmacol. 1993, 123:274-282.
7. Chen L.-J., Hecht S.S., Peterson L.A. Identification of cis-2-butene-1,4-dial as a microsomal metabolite of furan. Chem. Res. Toxicol. 1995, 8:903-906.
8. Byrns M.C., Predecki D.P., Peterson L.A. Characterization of nucleoside adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem. Res. Toxicol. 2002, 15:373-379.
9. 2-etheno-2'-deoxyguanosine adducts by cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem. Res. Toxicol. 2004, 17:1607-1613.
10. Peterson L.A., Naruko K.C., Predecki D.P. A reactive metabolite of furan, cis-2-butene-1,4-dial, is mutagenic in the Ames assay. Chem. Res. Toxicol. 2000, 13:531-534.
11. +/- mouse lymphoma cells. Mutat. Res. 2008, 657:127-132.
12. Peterson L.A. Electrophilic intermediates produced by bioactivation of furan. Drug Metab. Rev. 2006, 38:615-626.
13. Mortelmans K., Haworth S., Lawlor T., Speck W., Tainer B., Zeiger E. Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals. Environ. Mutagen. 1986, 8(Suppl 7):1-119.
14. Stich H.F., Rosin M.P., Wu C.H., Powrie W.D. Clastogenicity of furans found in food. Cancer Lett. 1981, 13:89-95.
15. - mouse lymphoma cell forward mutation assay. III. 72 coded chemicals. Environ. Mol. Mutagen. 1988, 12:85-154.
16. Glatt H., Schneider H., Liu Y. V79-hCYP2E1-hSULT1A1, a cell line for the sensitive detection of genotoxic effects induced by carbohydrate pyrolysis products and other food-borne chemicals. Mutat. Res. 2005, 580:41-52.
17. Durling L.J.K., Svensson K., Abramsson-Zetterberg L. Furan is not genotoxic in the micronucleus assay in vivo or in vitro. Toxicol. Ltt. 2007, 169:43-50.
18. Tweats D.J., Blakey D., Heflich R.H., Jacobs A., Jacobsen S.D., Morita T., Nohmi T., O'Donovan M.R., Sasaki Y.F., Sofuni T., Tice R. Report of the IWGT working group on strategy/interpretation for regulatory in vivo tests. II. Identification of in vivo-only positive compounds in the bone marrow micronucleus test. Mutat. Res. 2007, 627:92-105.
19. Manjanatha M.G., Aidoo A., Shelton S.D., Bishop M.E., McDaniel L.P., Lyn-Cook L.E., Doerge D.R. Genotoxicity of acrylamide and its metabolite glycidamide administered in drinking water to male and female Big Blue mice. Environ. Mol. Mutagen. 2006, 47:6-17.
20. Mei N., McDaniel L.P., Dobrovolsky V.N., Guo X., Shaddock J.G., Mittelstaedt R.A., Azuma M., Shelton S.D., McGarrity L.J., Doerge D.R., Heflich R.H. The genotoxicity of acrylamide and glycidamide in Big Blue rats. Toxicol. Sci. 2010, 115:412-421.
21. Wilson D.M., Goldsworthy T.L., Popp J.A., Butterworth B.E. Evaluation of genotoxicity, pathological lesions, and cell proliferation in livers of rats and mice treated with furan. Environ. Mol. Mutagen. 1992, 19:209-222.
22. Reynolds S.H., Stowers S.J., Patterson R.M., Maronpot R.R., Aaronson S.A., Anderson M.W. Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science 1987, 237:1309-1316.
23. Leopardi P., Cordelli E., Villani P., Cremona T.P., Conti L., De Luca G., Crebelli R. Assessment of in vivo genotoxicity of the rodent carcinogen furan: evaluation of DNA damage and induction of micronuclei in mouse splenocytes. Mutagenesis 2010, 25:57-62.
24. Cordelli E., Leopardi P., Villani P., Marcon F., Macri C., Caiola S., Siniscalchi E., Conti L., Eleuteri P., Malchiodi-Albedi F., Crebelli R. Toxic and genotoxic effects of oral administration of furan in mouse liver. Mutagenesis 2010, 25:305-314.
25. 14C]furan in the male F344 rat. J. Toxicol. Environ. Health 1991, 34:245-257.
26. Hickling K.C., Hitchcock J.M., Oreffo V., Mally A., Hammond T.G., Evans J.G., Chipman J.K. Evidence of oxidative stress and associated DNA damage, increased proliferative drive, and altered gene expression in rat liver produced by the cholangiocarcinogenic agent furan. Toxicol. Pathol. 2010, 38:230-243.
27. Hickling K.C., Hitchcock J.M., Chipman J.K., Hammond T.G., Evans J.G. Induction and progression of cholangiofibrosis in rat liver injured by oral administration of furan. Toxicol. Pathol. 2010, 38:213-219.
28. Dobrovolsky V.N., Boctor S.Y., Twaddle N.C., Doerge D.R., Bishop M.E., Manjanatha M.G., Kimoto T., Miura D., Heflich R.H., Ferguson S.A. Flow cytometric detection of Pig-A mutant red blood cells using an erythroid-specific antibody: application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats. Environ. Mol. Mutagen. 2010, 51:138-145.
29. Dobrovolsky V.N., Elespuru R.K., Bigger C.A.H., Robison T.W., Heflich R.H. Monitoring humans for somatic mutation in the endogenous PIG-A gene using red blood cells. Environ. Mol. Mutagen. 2011, 52:784-794.
30. Dobrovolsky V.N., Shaddock J.G., Heflich R.H. Analysis of in vivo mutation in the Hprt and Tk genes of mouse lymphocytes. Methods Mol. Biol. 2005, 291:133-144.
31. +/- mice: automated scoring of lymphocyte clones using a fluorescent viability indicator. Environ. Mol. Mutagen. 2000, 36:283-291.
32. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
33. Tice R.R., Agurell E., Anderson D., Bulinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.-C., Sasaki Y.F. Single cell gel/Comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
34. Sixth Framework Programme, SSPE-CT-2006-44393: Role of Genetic and Non-Genetic Mechanisms in Furan Risk, 2009, (site accessed 8-20-11). http://www.furan-ra.toxi.uni-wuerzburg.de/uploads/media/D8.2-Database.pdf.
35. U.S. FDA/NCTR (U.S. Food and Drug Administration/National Center for Toxicological Research), National Center for Toxicological Research Annual Report 2009-2010, (site accessed 8-20-11). http://www.fda.gov/downloads/aboutfda/centersoffices/nctr/researchaccomplishmentsplans/ucm200349.pdf.
36. WHO (World Health Organization), Furan, in: Evaluation of Certain Contaminants in Food, Seventy-Second Report of the Joint FAO/WHO Expert Committee on Food Additives, WHO Technical Report Series 959, 2011, pp. 48-55, (accessed 8-26-2011). http://whqlibdoc.who.int/trs/WHO_TRS_959_eng.pdf.
37. U.S. EPA (U.S. Environmental Protection Agency), Guidelines for Carcinogen Risk Assessment, EPA/630/P-03/001B, March 2005, (accessed 9-22-11). http://www.epa.gov/ttnatw01/cancer_guidelines_final_3-25-05.pdf.
38. U.S. EPA (U.S. Environmental Protection Agency), Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Cancinogens, EPA/630R-03/003F, March 2005, (accessed 9-22-11). http://www.epa.gov/ttn/atw/childrens_supplement_final.pdf.
39. Fransson-Steen R., Goldsworthy T.L., Kedderis G.L., Maronpot R.R. Furan-induced liver cell proliferation and apoptosis in female B6C3F1 mice. Toxicology 1997, 118:195-204.
40. EFSA (European Food Safety Authority), Report of the Scientific Panel on Contaminants in the Food Chain on Provisional Findings on Furan in Food (Question No. EFSA-Q-2004-109), EFSA J. 137 (2004) 1-20.
41. Heppner C.W., Schlatter J.R. Data requirements for risk assessment of furan in food. Food Additives Contaminants 2007, 24(Suppl 1):114-121.
42. Carfagna M.A., Held S.D., Kedderis G.L. Furan-induced cytolethality in isolated rat hepatocytes: correspondence with in vivo dosimetry. Toxicol. Appl. Pharmacol. 1993, 123:265-273.
43. Moser G.J., Foley J., Burnett M., Goldsworthy T.L., Maronpot R. Furan-induced dose-response relationships for liver cytotoxicity, cell proliferation, and tumorigenicity (furan-induced liver tumorigenicity). Exp. Toxicol. Pathol. 2009, 61:101-111.
44. Moore M.M., Heflich R.H., Haber L.T., Allen B.C., Shipp A.M., Kodell R.L. Analysis of in vivo mutation data can inform cancer risk assessment. Reg. Toxicol. Pharmacol. 2008, 51:151-161.
45. 6-methylguanine in bone marrow and not in the spleen. Carcinogenesis 1996, 17:2183-2191.
46. Walker V.E., Jones I.M., Crippen T.L., Meng Q., Walker D.M., Bauer M.J., Reilly A.A., Tates A.D., Nakamura J., Upton P.B., Skopek T.R. Relationships between exposure, cell loss and proliferation, and manifestation of Hprt mutant T cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea. Mutat. Res. 1999, 431:371-388.
47. Miura D., Dobrovolsky V.N., Kimoto T., Kasahara Y., Heflich R.H. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat. Res. 2009, 677:86-92.
48. Kimoto T., Suzuki K., X.m.Kobayashi, Dobrovolsky V.N., Heflich R.H., Miura D., Kasahara Y. Manifestation of Pig-a mutant bone marrow erythroids and peripheral blood erythrocytes in mice treated with N-ethyl-N-nitrosourea: direct sequencing of Pig-a cDNA from bone marrow cells negative for GPI-anchored protein expression. Mutat. Res. 2011, 723:36-42.
49. Aidoo A., Lyn-Cook L.E., Heflich R.H., George E.O., Casciano D.A. The effect of time after treatment, treatment schedule and animal age on the frequency of 6-thioguanine-resistant T-lymphocytes induced in Fischer 344 rats by N-ethyl-N-nitrosourea. Mutat. Res. 1993, 298:169-178.
50. Thybaud V., Dean S., Nohmi T., de Boer J., Douglas G.R., Glickman B.W., Gorelick N.J., Heddle J.A., Heflich R.H., Lambert I., Martus H.-J., Mirsalis J.C., Suzuki T., Yajima N. In vivo transgenic mutation assay. Mutat. Res. 2003, 540:141-151.
51. Rothfuss A., Honma M., Czich A., Aardema M.J., Burlinson B., Galloway S., Hamada S., Kirkland D., Heflich R.H., Howe J., Nakajima M., O'Donovan M., Plappert-Helbig U., Priestley C., Recio L., Schuler M., Uno Y., Martus H.-J. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing. Mutat. Res. 2011, 723:108-120.
52. Hartmann A., Agurell E., Beevers C., Brendler-Schwaab S., Burlinson B., Clay P., Collins A., Smith A., Speit G., Thybaud V., Tice R.R. Recommendations for conducting the in vivo alkaline Comet assay. Mutagenesis 2003, 18:45-51.
53. W. Ding, R.H. Heflich, M.G. Pearce, G. White, R.A. Mittelstaedt, J.G. Shaddock, P.L. McDaniel, D.R. Doerge, M.G. Manjanatha, A. Aidoo, Genotoxity of furan in F344 rats using the in vivo Comet and micronucleus assays, The Toxicologist, Supplement to Toxicological Sciences (2011) p. 332, PS 1548, (accessed 12-5-11). http://www.toxicology.org/AI/PUB/Toxicologist11.pdf.